Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies

Y Yamazaki, N Zhao, TR Caulfield, CC Liu… - Nature Reviews …, 2019 - nature.com
Polymorphism in the apolipoprotein E (APOE) gene is a major genetic risk determinant of
late-onset Alzheimer disease (AD), with the APOE* ε 4 allele conferring an increased risk …

[HTML][HTML] Cholesterol metabolism in neurodegenerative diseases: molecular mechanisms and therapeutic targets

L Dai, L Zou, L Meng, G Qiang, M Yan, Z Zhang - Molecular neurobiology, 2021 - Springer
Cholesterol is an indispensable component of the cell membrane and plays vital roles in
critical physiological processes. Brain cholesterol accounts for a large portion of total …

[HTML][HTML] Are dementia with Lewy bodies and Parkinson's disease dementia the same disease?

KA Jellinger, AD Korczyn - BMC medicine, 2018 - Springer
Abstract Background Dementia with Lewy bodies (DLB) and Parkinson's disease dementia
(PDD), which share many clinical, neurochemical, and morphological features, have been …

[HTML][HTML] Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies

KA Jellinger - Journal of neural transmission, 2018 - Springer
Dementia with Lewy bodies (DLB) and Parkinson's disease-dementia (PDD), although
sharing many clinical, neurochemical and morphological features, according to DSM-5, are …

[HTML][HTML] LRP1 is a neuronal receptor for α-synuclein uptake and spread

K Chen, YA Martens, A Meneses, DH Ryu, W Lu… - Molecular …, 2022 - Springer
Background The aggregation and spread of α-synuclein (α-Syn) protein and related
neuronal toxicity are the key pathological features of Parkinson's disease (PD) and Lewy …

Neuropathologic substrates of Parkinson disease dementia

DJ Irwin, MT White, JB Toledo, SX Xie… - Annals of …, 2012 - Wiley Online Library
Objective: A study was undertaken to examine the neuropathological substrates of cognitive
dysfunction and dementia in Parkinson disease (PD). Methods: One hundred forty patients …

[HTML][HTML] Cognitive impairment in Parkinson's disease: a report from a multidisciplinary symposium on unmet needs and future directions to maintain cognitive health

JG Goldman, BA Vernaleo, R Camicioli… - npj Parkinson's …, 2018 - nature.com
People with Parkinson's disease (PD) and their care partners frequently report cognitive
decline as one of their greatest concerns. Mild cognitive impairment affects approximately 20 …

The epidemiology of dementia associated with Parkinson disease

D Aarsland, MW Kurz - Journal of the neurological sciences, 2010 - Elsevier
Several recent studies have shown that dementia is common in Parkinson's disease (PD),
and that in some patients, cognitive impairment occurs even at the time of diagnosis. The …

Metals and Parkinson's disease: mechanisms and biochemical processes

G Bjorklund, V Stejskal, MA Urbina… - Current Medicinal …, 2018 - ingentaconnect.com
Genetic background accounts for only 5 to 10% of the reported cases of Parkinson's disease
(PD), while the remaining cases are of unknown etiology. It is believed that environmental …

The epidemiology of dementia associated with Parkinson's disease

D Aarsland, MW Kurz - Brain pathology, 2010 - Wiley Online Library
Parkinson's disease (PD) is the second most common neurodegenerative illness after
Alzheimer's disease (AD). Cognitive impairment and dementia are common features in PD …